openPR Logo
Press release

Deferoxamine Mesylate Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

05-16-2025 05:40 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Deferoxamine Mesylate Market

The global market for Deferoxamine Mesylate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Deferoxamine Mesylate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10G8844/Global_Deferoxamine_Mesylate_Market_Outlook_2022

Asia-Pacific market for Deferoxamine Mesylate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Deferoxamine Mesylate include Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group, New-In CO., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

By Type
• ≥98% Purity

By Application
• Anemia
• Acute Iron Poisoning

Key Companies
Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group, New-In CO.

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-10G8844/global-deferoxamine-mesylate

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deferoxamine Mesylate Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports here

News-ID: 4021109 • Views:

More Releases from Valuates Reports

Photonic Crystal Surface-emitting Lasers (PCSEL)‌ Market Revenue, Insights, Ov …
Photonic Crystal Surface-emitting Lasers (PCSEL) Market Size The global market for Photonic Crystal Surface-emitting Lasers (PCSEL) was valued at US$ 135 million in the year 2024 and is projected to reach a revised size of US$ 234 million by 2031, growing at a CAGR of 8.6% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-12O18911/Global_Photonic_Crystal_Surface_emitting_Lasers_PCSEL_Market?utm_source=Openpr&utm_medium=Referral The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications
Foldable Laptop Market Revenue, Insights, Overview, Outlook, Analysis | Valuates …
Foldable Laptop Market The global market for Foldable Laptop was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6R15803/Global_Foldable_Laptop_Market?utm_source=Openpr&utm_medium=Referral North American market for Foldable Laptop is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast
Skin-feeling PETG Decorative Film Market Revenue, Insights, Overview, Outlook, A …
Skin-feeling PETG Decorative Film Market Skin-feel PETG decorative film is a type of PETG decorative film with a special treatment on its surface, which gives it a texture similar to skin, commonly used in phone cases, smartwatch straps, and other consumer electronic products that require a comfortable touch. In addition to the general properties of PETG, such as transparency, durability, and recyclability, this film particularly emphasizes its flexibility and skin-like texture
Silicone Rubber Test Socket Market Revenue, Insights, Overview, Outlook, Analysi …
Silicone Rubber Test Socket Market Size The global market for Silicone Rubber Test Socket was valued at US$ 206 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 6.7% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15S18466/Global_Silicone_Rubber_Test_Socket_Market?utm_source=Openpr&utm_medium=Referral By Type • Pitch:≤0.3P • Pitch:0.3-0.8P • Pitch: ≥0.8P By Application • Pitch:≤0.3P • Pitch:0.3-0.8P • Pitch: ≥0.8P Key Companies ISC, TSE Co., Ltd., JMT (TFE), SNOW Co., Ltd., SRC Inc., Smiths Interconnect, WinWay Technology, Ironwood

All 5 Releases


More Releases for Deferoxamine

Evolving Market Trends In The Medical Deferoxamine Mesylate Industry: Expanding …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What Is the Expected Medical Deferoxamine Mesylate Market Size During the Forecast Period? In recent years, there has been substantial growth in the market size for medical deferoxamine mesylate. The market, which was valued at $1.18 billion in 2024, is anticipated to increase to $1.29 billion in 2025, reflecting a compound annual growth rate
Medical Deferoxamine Mesylate Market to Reflect Holistic Expansion with Signific …
The Medical Deferoxamine Mesylate Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. It's like a compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future. This report becomes a strategic ally for companies, stakeholders, and industry players, offering
Deferoxamine Market Growth Analysis by Emerging Trends, Key Manufacturers and In …
In 2023, the Deferoxamine market was valued at USD 0.42 billion. It is anticipated to grow to USD 0.46 billion in 2024 and reach USD 1.03 billion by 2032, reflecting a compound annual growth rate (CAGR) of about 10.57% over the forecast period from 2024 to 2032. Market Trends The Deferoxamine market is seeing several key trends. The growing incidence of conditions such as thalassemia and hemochromatosis, which cause iron overload, is
Medical Deferoxamine Mesylate Market Will Generate Record Revenue by 2029
The Medical Deferoxamine Mesylate Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2023-2029). Deferoxamine Mesylate is a medication used for the treatment of acute iron poisoning and chronic iron overload in patients who require regular blood transfusions. It is a chelating agent that binds to iron in the bloodstream and helps remove it from the body. Medical Deferoxamine Mesylate Market research report
Deferoxamine Mesylate Market Rising Trends,Demands and Growing Business Opportun …
LOS ANGELES, United States: The global Deferoxamine Mesylate market is researched with great precision and in a comprehensive manner to help you identify hidden opportunities and become informed about unpredictable challenges in the industry. The authors of the report have brought to light crucial growth factors, restraints, and trends of the global Deferoxamine Mesylate market. The research study offers complete analysis of critical aspects of the global Deferoxamine Mesylate market,
Hemochromatosis/Iron Overload Therapeutics - Key Players Analysis La Jolla Pharm …
Hyperlipidemia therapeutics currently exhibits a pipeline with nine drug candidates. According to the research findings, a majority of the drug candidates for the treatment of hemochromatosis are being developed to be administered by the subcutaneous route, which facilitates the absorption of the drug as iron chelator drugs such as deferoxamine, that are poorly absorbed from the gastrointestinal tract. Download report sample at: https://www.psmarketresearch.com/market-analysis/iron-overload-therapeutics-pipeline/report-sample *Hemochromatosis Therapeutics Pipeline Involves Development of Gene Suppressor Therapy Hemochromatosis most